Nasdaq News

Understanding Volatility in Oil Prices

5 years 5 months ago
In this episode of Industry Focus: Energy, Nick Sciple and Tracy Shuchart, from The Family Office, do a deep dive into the oil and gas industry. Their conversation covers a wide swath of the oil and gas market, from an impending wall of debt facing shale producers, to how the
The Motley Fool

What Factors Will Drive United Airlines' Revenues In 2020?

5 years 5 months ago
United Airlines (NASDAQ: UAL) results came fairly in-line with the market expectations for the full year 2019. Though the company’s fleet plan included 30 Boeing 737 MAX aircraft for 2019, it received only four aircraft before the FAA grounding order last March. The impact o
Trefis

Should Sirius XM's Revenue Growth Outlook For 2020 Be A Concern?

5 years 5 months ago
Sirius XM Radio (NASDAQ: SIRI) has guided for a revenue growth of just 4% to $8.1 billion in 2020, which would be the lowest in the company’s history. This will follow a 35% revenue growth in 2019, which was largely due to the acquisition of Pandora’s business. The compan
Trefis

Could Google Acquire Tesla For $250 Billion?

5 years 5 months ago
In the following analysis, we take a look at why Tesla (NASDAQ:TSLA) could be an attractive acquisition target for Google (NASDAQ:GOOG). We break down our analysis into three parts: what Tesla would stand to gain, what Google would stand to gain, and a scenario where Tesla
Trefis

Comparing Tesla With Toyota

5 years 5 months ago
Tesla (NASDAQ:TSLA) stock is up by almost 2.5x over the last three months, making it the world’s second most valuable automaker, behind Toyota, which in many respects is the benchmark of profitability and efficiency in the auto industry. In this analysis, we compare Tesla
Trefis

How Soon Can Trip.Com's Revenues Reach The $6-Billion Mark?

5 years 5 months ago
Trip.Com‘s (NASDAQ: TCOM) Transportation Ticketing, which generates revenues from the reservation of air tickets, railway tickets, and other related services, is expected to contribute $2.4 billion to Trip.Com’s 2020 revenues, making up 40% of the company’s $6 billion i
Trefis

ACST Plunges On Data Delay, MREO On Watch, AQST Faces FDA In Sep.

5 years 5 months ago
(RTTNews) - Today's Daily Dose brings you news about an update on Acasti Pharma's TRILOGY 2 study, Biohaven's disappointing results from Generalized Anxiety Disorder trial, Aquestive Therapeutics' date with FDA, the clinical hold on LogicBio Therapeutics' methylmalonic acidemia
RTTNews
Checked
32 minutes 5 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed